JPS6236163A - Dietary food - Google Patents
Dietary foodInfo
- Publication number
- JPS6236163A JPS6236163A JP60175763A JP17576385A JPS6236163A JP S6236163 A JPS6236163 A JP S6236163A JP 60175763 A JP60175763 A JP 60175763A JP 17576385 A JP17576385 A JP 17576385A JP S6236163 A JPS6236163 A JP S6236163A
- Authority
- JP
- Japan
- Prior art keywords
- vitamin
- soybean saponin
- weight
- dietary food
- saponin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は、大豆サポニン及び褐藻エキスを主成分とする
ダイエツト食品であって、特に脂質代謝促進、過酸化脂
質抑制作用を有すると共に月経前症候群(以下FMSと
略称する)に有効なダイエツト食品に関するものである
。Detailed Description of the Invention [Industrial Application Field] The present invention is a diet food containing soybean saponin and brown algae extract as main ingredients, which has the effect of promoting lipid metabolism and suppressing lipid peroxide, and is effective in treating premenstrual syndrome. (hereinafter abbreviated as FMS).
従来、大豆から抽出されたいわゆる大豆サポニンには、
肥満抑制作用等があることが知られている。Conventionally, so-called soy saponins extracted from soybeans include
It is known to have an anti-obesity effect.
即ち、一般に、肥満は過剰に摂取した炭水化物や脂質が
皮下脂肪として蓄積されるだけでなく、むしろ肥満体の
人特有彦脂質の代謝異状に起因していることが知られて
いる。この代謝異状が血液の性状に及ぼす影響としては
、血液中のコレステロール、中性脂肪及び遊離脂肪酸の
濃度が増加することがあげられているが、大豆サポニン
は、これらの血中のコレステロール、中性脂肪及び遊離
脂肪酸を減少させる作用を有すると共に、動脈硬化の発
生要因の一つであり、且つ、種々のビタミンを破壊し脂
肪酸代謝障害をもたらし肥満の原因の一つである過酸化
脂質生成抑制作用等を有することも知られている(特開
昭56−73025号公報)
一方、褐藻類に属するIFucua Vesiculo
aus 。That is, it is generally known that obesity is caused not only by the accumulation of excessively ingested carbohydrates and lipids as subcutaneous fat, but also by abnormalities in the metabolism of fat that are characteristic of obese people. The effects of this metabolic abnormality on blood properties include an increase in the concentration of cholesterol, neutral fats, and free fatty acids in the blood. It has the effect of reducing fat and free fatty acids, and also has the effect of suppressing the production of lipid peroxide, which is one of the causes of arteriosclerosis, and which destroys various vitamins, causes fatty acid metabolism disorder, and is one of the causes of obesity. (Japanese Unexamined Patent Publication No. 56-73025) On the other hand, IFucua Vesiculo, which belongs to brown algae,
aus.
Lam1nalia C1ouatoni 、As
cophyllum Nodoaumを冷水で洗浄し
た後塩化す) IJウム溶液で膨潤させ高粘度のコロイ
ド状とした後遠心分離して得られる淡褐色〜淡黄色のバ
ルブ状物質を低温下で真空乾燥して得られる粉末状製品
(商品名アルゲコロイド)である海藻エキスは、多量の
ヨードを含み、皮膚化粧料、毛髪化粧料への配合成分と
して使用されている外、ローヤルゼリー、ニンニクエキ
ス等に配合され、健康食品として利用されていることは
周知のことである。Lam1nalia C1ouatoni, As
Cophyllum Nodoaum is washed with cold water and then chlorinated) It is swollen with IJum solution to form a highly viscous colloid, and then centrifuged.The light brown to light yellow bulb-shaped substance is obtained by vacuum drying at low temperature. Seaweed extract, which is a powdered product (trade name Algecolloid), contains a large amount of iodine and is used as an ingredient in skin and hair cosmetics, as well as in royal jelly, garlic extract, etc., and is used as a health food. It is well known that it is used as
また、ビタミンa及びその誘導体は、脂肪酸の代謝に不
可欠のものであると同時に、過酸化脂質の生成を抑制す
るのみならず、生成した過酸化脂質を減少させる作用を
有することも知られている。In addition, vitamin A and its derivatives are essential for fatty acid metabolism, and are also known to have the effect of not only suppressing the production of lipid peroxide but also reducing the amount of lipid peroxide produced. .
また、ビタミン式については、種々の病気の治療に使わ
れている外、PMg(月経前症候群)に有効であること
が知られている。In addition, vitamin formulas are used to treat various diseases and are known to be effective for PMg (premenstrual syndrome).
即ち、月経期の40〜60%の女性が、うつ状態、無気
力、過敏症、頭痛、吐き気、或いはむくみ、太ってくる
、孔部膨張等の精神・神経的な症状或いは身体的症状に
脳まされているが、このようなFMSの状態にある女性
に1日当#)50〜100〜のビタミン式の投与により
平均50〜60%、頭痛などに対しては約80%を寛解
しうろことが報告されている。In other words, 40-60% of women during their menstrual period suffer from mental and neurological symptoms or physical symptoms such as depression, lethargy, irritability, headaches, nausea, swelling, weight gain, orifice swelling, etc. However, by administering 50 to 100 vitamins per day to women with FMS, they can achieve an average of 50 to 60% remission, and about 80% of symptoms such as headaches. has been reported.
本発明は、肥満を有効に抑制すると同時に、FMSにも
有効なダイエツト食品を提供することを目的とする。An object of the present invention is to provide a diet food that effectively suppresses obesity and is also effective for FMS.
本発明は、大豆サポニン及び褐藻エキスを主成分とする
か、又はこれに更にビタミン式及び鳥を配合してなるダ
イエツト食品であって、本発明者は、大豆サポニン、ビ
タミン式及びへの脂質代謝作用について種々検討してい
たところ、その作用、機構については明らかでないが、
これらに褐藻エキスを配合することにより、その脂質代
謝作用を向上せしめうろことを見出だし本発明をなすに
到った。The present invention is a diet food which contains soybean saponin and brown algae extract as main ingredients or further contains vitamin formula and chicken. After various studies on the effect, it was found that the effect and mechanism were not clear.
By blending brown algae extract with these, it was discovered that the lipid metabolic effect of the scales can be improved, and the present invention has been completed.
即ち、前にも述べたように、大豆サポニンは脂質代謝に
有効であることが知られておシ、その投与量は成人に対
し1日当り50〜1000■好ましくは100〜300
〜であるが、大豆サポニンに対し、褐藻エキスを配合し
たところ、大豆サポニン単独で投与する場合に比し、夕
景で同様な効果のあることを見出だした。That is, as mentioned earlier, soybean saponin is known to be effective for lipid metabolism, and the dosage for adults is 50 to 1000 per day, preferably 100 to 300.
However, when brown algae extract was added to soybean saponin, it was found that the same effect on evening scenery was obtained as compared to when soybean saponin was administered alone.
大豆サポニンに対する褐藻エキス(粉末)の配合量は大
豆サポニン1重量部に対しく12〜1重量部加えると有
効である。It is effective to add brown algae extract (powder) to soybean saponin in an amount of 12 to 1 part by weight per 1 part by weight of soybean saponin.
大豆サポニンには、複数のサポニンが含まれており、そ
のうち数種の化学構造が明らかにされているが、本発明
においては大豆サポニンから分離した特定の構造のもの
を用いてもよく或いは混合物のま\で用いてもよい。Soybean saponin contains a plurality of saponins, and the chemical structures of several of them have been clarified, but in the present invention, one with a specific structure separated from soybean saponin may be used, or a mixture thereof May be used in ma\.
また、ビタミン式及び烏を配合するのは、大豆サポニン
の脂質代謝作用を補助せしめるためであって、通常1日
当りの必要量と言われる量を摂取せしめるに足る量で配
合すればよい。即ち、馬については1日当り1■以上の
量、烏については1日当り50〜400■の摂取量とな
る量で添加するとよい。Furthermore, the reason why vitamin formula and crow are blended is to assist the lipid metabolic action of soybean saponin, and it is sufficient to blend the soybean saponin in an amount sufficient to ingest what is usually said to be the required amount per day. That is, for horses, it is preferable to add it in an amount of 1 or more pounds per day, and for crows, it is preferable to add it in an amount that provides an intake of 50 to 400 pounds per day.
これらのビタミン式及び為を配合することによシ脂質代
謝をより有効に行わせうると共に、特に八を配合するこ
とにより女性のPMB 、特にむくみや太ってくるのを
防止しうる。By incorporating these vitamin formulas and vitamins, lipid metabolism can be carried out more effectively, and by incorporating 8 in particular, women's PMB, especially swelling and weight gain, can be prevented.
本発明のダイエツト食品は、粉末状あるいは錠剤の形態
で用いうるが、カルシウム成分等の他の栄養剤を配合し
てもよく、また賦形剤として通常用いられている成分を
配合しうろことは勿論である。The diet food of the present invention can be used in the form of powder or tablet, but it may also contain other nutritional supplements such as calcium components, and may not contain ingredients commonly used as excipients. Of course.
賦形剤としては、乳糖、デキストリン、殿粉、リン酸カ
ルシウム、炭酸カルシウム、酸化マグネシウム、水酸化
アルミニウム、ステアリン酸カルシウムなどを用いうる
。As excipients, lactose, dextrin, starch, calcium phosphate, calcium carbonate, magnesium oxide, aluminum hydroxide, calcium stearate, etc. can be used.
投与例1
身長168a、体重75に9の男性に大豆サポニン25
■を含有する錠剤を朝および夕食後3錠づ\2ケ月間服
用させたが、体重に目立った変化は認められなかった。Administration example 1 Soy saponin 25 for a man with a height of 168 cm and a weight of 75.9 cm
The patient took 3 tablets containing ① in the morning and after dinner for 2 months, but no noticeable change in body weight was observed.
その後大豆サポニン25■、アルゲコロイド(商品名)
8■を含有する錠剤を同様に2ケ月間服用させたところ
体重が73時に減少した。After that, soybean saponin 25■, algecolloid (product name)
When the patient was given a tablet containing 8■ for 2 months, his body weight decreased by 73 hours.
投与例2
身長15B副、体重63ゆで、月経時むくみ感及び太っ
てくる感じの女性に、大豆サポニン30m9を含有する
錠剤を1日3錠づ\33ケ間服用させたが、体重、FM
S共に何等変化は認められなかったが、その後大豆サポ
ニン30■、アルゲコロイド(商品名)15m9、ビタ
ミンa酪酸エステル5■、ビタミンB&10■を含有す
る錠剤を1日3錠づ\33ケ間服用させたところ、2ケ
月目から体重が減少しはじめ、月経時のむくみ感がなく
なり、3ケ月後には体重60ゆとなり、月経時の太って
くる感じもなくなった。Administration Example 2 A woman with a height of 15B, a weight of 63cm, and a feeling of swelling during menstruation and gaining weight was given 3 tablets per day containing 30m9 of soybean saponin for 33 days, but the weight, FM
No changes were observed in either S, but after that, I took 3 tablets a day for 33 days containing 30 ■ soybean saponin, 15 m9 algecolloid (trade name), 5 ■ vitamin A butyrate ester, and vitamin B & 10 ■. After two months, her weight started to decrease and the feeling of swelling during menstruation disappeared, and after three months, she weighed 60 yu and no longer felt like she was gaining weight during menstruation.
投与例3
身長165cfm1体重66kgの男性に、大豆サポニ
ン301n9、ビタミンa6η、ビタミン烏IClIn
9を含有する錠剤を1日5錠づ\33ケ間服用させたが
、体重は殆んど変化しなかった。Administration example 3: Soybean saponin 301n9, vitamin a6η, vitamin karasu IClIn was given to a man with a height of 165 cfm and a weight of 66 kg.
Although the patient took 5 tablets containing 9 per day for 33 days, there was almost no change in her body weight.
その後、大豆サポニン501n9、アルゲコロイド10
m9、ビタミ7 B、 6 In9、ビタミンE810
■を含有する錠剤を1日3錠づ\服用させたところ、約
2ケ月後に体重が64に9に減少した。After that, soybean saponin 501n9, algecolloid 10
m9, vitamin 7 B, 6 In9, vitamin E810
When the patient took 3 tablets a day containing ①, her weight decreased from 64 to 9 after about 2 months.
Claims (1)
ット食品 2、大豆サポニン及び褐藻エキスを主成分とし、これに
ビタミンB_2及びビタミンB_6を配合してなる特許
請求の範囲第1項記載のダイエット食品[Claims] 1. Diet food containing soybean saponin and brown algae extract as main ingredients. 2. Claim 1 comprising soybean saponin and brown algae extract as main ingredients, and vitamin B_2 and vitamin B_6 added thereto. Diet foods listed in section
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP60175763A JPS6236163A (en) | 1985-08-12 | 1985-08-12 | Dietary food |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP60175763A JPS6236163A (en) | 1985-08-12 | 1985-08-12 | Dietary food |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS6236163A true JPS6236163A (en) | 1987-02-17 |
Family
ID=16001827
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP60175763A Pending JPS6236163A (en) | 1985-08-12 | 1985-08-12 | Dietary food |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6236163A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6132795A (en) * | 1998-03-15 | 2000-10-17 | Protein Technologies International, Inc. | Vegetable protein composition containing an isoflavone depleted vegetable protein material with an isoflavone containing material |
US6544566B1 (en) | 1999-04-23 | 2003-04-08 | Protein Technologies International, Inc. | Composition containing plant sterol, soy protein and isoflavone for reducing LDL cholesterol |
US7285297B1 (en) | 1999-04-23 | 2007-10-23 | Archer-Daniels-Midland Company | Method of reducing low density liproprotein cholesterol concentration |
-
1985
- 1985-08-12 JP JP60175763A patent/JPS6236163A/en active Pending
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6132795A (en) * | 1998-03-15 | 2000-10-17 | Protein Technologies International, Inc. | Vegetable protein composition containing an isoflavone depleted vegetable protein material with an isoflavone containing material |
US6544566B1 (en) | 1999-04-23 | 2003-04-08 | Protein Technologies International, Inc. | Composition containing plant sterol, soy protein and isoflavone for reducing LDL cholesterol |
US6572876B2 (en) | 1999-04-23 | 2003-06-03 | Solae, Llc | Administering a composition containing plant sterol, soy protein and isoflavone for reducing LDL-cholesterol |
US6579534B2 (en) | 1999-04-23 | 2003-06-17 | Solae, Llc | Composition containing soy hypocotyl material and plant sterol for reducing LDL-cholesterol |
US6669952B2 (en) | 1999-04-23 | 2003-12-30 | Solae, Llc | Composition containing isoflavone material and plant sterol for reducing LDL-cholesterol |
US7285297B1 (en) | 1999-04-23 | 2007-10-23 | Archer-Daniels-Midland Company | Method of reducing low density liproprotein cholesterol concentration |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI329516B (en) | Composition for preventing or ameliorating multiple risk factor syndromes and visceral fat-type obesity | |
US4735967A (en) | Method for desensitizing the gastrointestinal tract from food allergies | |
JP4588132B2 (en) | Food additives and health food | |
US6113949A (en) | Weight control product and method of treating hyperlipidemia and increasing vigor with said product | |
ES2340510T3 (en) | USE OF RENTAL-FURANS FOR THE PREPARATION OF A MEDICINAL PRODUCT INTENDED FOR THE TREATMENT OF OBESITY AND FOR THE COSMETIC TREATMENT OF THE EXCEESS OF WEIGHT. | |
JPS6212984B2 (en) | ||
CN1972661B (en) | Use of furan alkyls for a cellulite cosmetic treatment | |
JPS6236163A (en) | Dietary food | |
JP4824205B2 (en) | Female hormone abnormal disorder improving agent | |
KR100419121B1 (en) | A functional food Containing herbes composition for female menopausal disorder | |
KR20160070912A (en) | A composition for the prevention or treatment of abnormal weight loss comprising Citrus Unshiu Peel extract | |
Gross | Nonpellagrous eruptions due to deficiency of vitamin B complex | |
JP4907280B2 (en) | Lipase inhibitor | |
JP2002360220A (en) | Health supplement food having improving action for interruption in circulation of blood | |
JP3832871B2 (en) | Lipase inhibitor | |
JP2524067B2 (en) | Foods that improve lipid metabolism | |
AU6282796A (en) | Fish oil and garlic nutritive composition | |
WHARTON | Protein energy malnutrition: problems and priorities | |
Ereaux | Facts, fads and fancies in the treatment of acne vulgaris | |
KR20000018977A (en) | Production process and food composition for adjusting weight and blood sugar prepared by using wax gourd and residual thereof | |
JPH08133983A (en) | Extract of aspalathus linealis and its use | |
US3894153A (en) | Method of medical treatment of asthma | |
JPS60172926A (en) | Healthy food | |
JP4359205B2 (en) | Skin moisturizing food | |
JP2000157207A (en) | Functional food |